Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Vibration therapy may help seniors fight frailty

NCT ID NCT07205133

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether whole body vibration therapy, added to usual care, can improve muscle mass, strength, and function in older adults who are starting to become frail. About 40 people aged 65 and older will be randomly assigned to receive either vibration therapy plus usual care or usual care alone. Researchers will measure changes in leg and hand strength and muscle mass over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy Volunteer or Patients aged 65 and above, * Clinical frailty Scale (CFS) score of 3-4, * Independently ambulating without any aid * willingness and consent to participate in the study and ability to travel to the study-site for the measurements and interventions, and * participants with no regular exercise habits (defined as less than 150mins/week of moderate intensity aerobic exercise and less than twice a week of strengthening exercises)for past 3 months. Exclusion Criteria: * current active enrolment into any Day Rehab or community exercise program, * contraindications to WBVT machine usage (see below), * diagnosis of dementia, * history of Diabetes Mellitus * BMI ≤20kg/m2, * recent hospital admissions within the last 3 months, * end stage organ failure, * chronic diseases which are not well managed, for example, poorly controlled hypertension, * New York Heart Association (NYHA) score II and above for patients with history of heart failure and * MUST Score ≥1. Contraindications to WBVT: PRIMARY CONTRAINDICATIONS TO WBVT * Pregnancy * Acute thrombosis (acute vascular occlusion) * Artificial joints in stimulated body regions * Fresh fractures in stimulated body regions * Within 3 months post surgery/procedure and/or any fresh wounds and scars in the stimulated body regions * or if the wound healing is not yet completely finished. SECONDARY CONTRAINDICATIONS TO WBVT * Acute inflammation of the musculoskeletal system, activated arthrosis or * arthropathy (e.g. acute inflammation and swelling in joints). * Acute tendinopathies in stimulated body regions (acute tendonitis) * Acute hernias (tissue ruptures) * Acute discopathy (acute disc-related back problem) * Stone disease of the bile ducts and urinary tract * Rheumatoid Arthritis * Epilepsy due to secondary risk of injury

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Changi General Hospital

    RECRUITING

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.